Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 15
- Markets & Stocks
Cannabis Stocks Today — Wednesday 4 June 2026: MSOS Falls to .74 as US Operators Extend Losses
The cannabis sector is entering Wednesday’s pre-market session in broadly negative territory, with the US benchmark fund MSOS now sitting at $4.74, a retreat from $5.05 at Tuesday’s close.
- M&A Activity
AYR Wellness Completes Asset Handover as MSO Sector’s Largest Collapse Draws to a Close
AYR Wellness (CSE: AYR.A) has finalised the transfer of its Florida, New Jersey and Nevada cannabis operations to Arboretum Bidco LLC, bringing the state-by-state handover of assets to a close in what amounts to the largest restructuring in multi-state operator (MSO) history.
- Cannabis Daily News
Cannabis News Today — Tuesday 3 June 2026: Congress blocks hemp relief as Germany’s drug chief breaks with party line
Tuesday’s cannabis headlines ranged from Capitol Hill to Berlin.
- UK & Europe
Germany’s Drug Commissioner Backs Cannabis Pilot Projects in Break With CDU Party Line
Ever since the Christian Democratic Union (CDU) became the largest party in Germany’s ruling coalition government in February 2025, the country’s booming cannabis industry has been bracing for a crackdown.
- Markets & Stocks
Cannabis Stocks Today — Monday 1 June 2026: MSOS Climbs to $5.01 as IM Cannabis and iPower Lead NASDAQ Gains
Cannabis equities begin June in mixed fashion, with the sector’s exchange-listed names showing a slight positive bias while OTC-traded US multi-state operators carry the weight of last Friday’s declines into Monday’s session.
- Investment & Finance
Cannabis at an Inflexion Point: Why Capital Is Missing the Opportunity
For much of the past five years, the cannabis industry has been defined by disappointment.
- Cannabis Daily News
Cannabis News Today — Sunday 1 June 2026: Rescheduling under legal strain as Tennessee confirms THCA deadline
The legal soundness of the United States’ cannabis rescheduling process came under renewed scrutiny on Sunday as fresh analysis argued that the post-Chevron regulatory landscape may expose the DEA’s scheduling procedures to constitutional challenge.
- Medical Cannabis
Vertanical Secures Milestone FDA Breakthrough Designation for Cannabis Pain Drug Ahead of Imminent European Launch
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to VER-01, the flagship full-spectrum cannabis drug from Munich-based Vertanical, putting it in prime position to become the first FDA-approved cannabis-derived medicine for pain, and only the second such approval since Epidiolex in 2018.
- Industry Trends
Cannabis Europa London 2026: Key Insights, Day 2
Live Cannabis Europa 2026 London, UK From Plant to Patient: Why Genetics Must Lead Medical Cannabis Outcomes Arjan Roskam, Green House Genetics; Dave Auger, Big League Genetics; Adele Hollman, Sanity Group; moderated by Alex Fraser, Grow Group Telemedicine in Germany: Maturity, Regulation and What Comes Next Kristine Lütke, 365 Sherpas GmbH; Dirk Heitepriem, German Cannabis…
- Events
Business of Cannabis Awards 2026: Our Esteemed Winners
As the sun finally dipped over London on the hottest day of the year, the buzz that had filled the Barbican throughout the first day of Cannabis Europa London 2026 moved a few streets east to 83 Rivington, as the tone shifted from debate to celebration.
- Industry Trends
Cannabis Europa London 2026 – Key Insights, Day 1
Live Cannabis Europa 2026 London, UK Cannabis Europa London is back at The Barbican Centre for two days of conversations with global cannabis leaders, policymakers, industry analysts and patient representatives, and, as ever, the sun has shown up.
- Press releases
Tilray Medical Brings Global Medical Cannabis Expertise to Cannabis Europa London 2026
Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), today announced its participation in Cannabis Europa London 2026, one of Europe’s leading forums for medical cannabis policy, science, and regulation.
